Imagine a world where doctors are able to target and remove infected cells, pathogens, toxins, or even viruses directly from a patient's bloodstream. At MediSieve we are working towards bringing this dream into a reality. Our Magnetic Blood Filtration System is a device-therapeutic combination that filters harmful substances from the bloodstream using magnetic forces.

If you've always dreamt of making a global impact, MediSieve is the place to be! The platform nature of our technology enables us to make a difference in treating humanity's most serious diseases, with the first product targeting hyperinflammation in conditions such as COVID-19, Sepsis, and Cytokine Release Syndrome.

Join Our Team As

Latest News

MediSieve Receives Approval for First-in-Man Clinical Investigation

MediSieve Receives Approval for First-in-Man Clinical Investigation
May 24, 2022

Radboud University Medical Center will perform the first trial of the Novel Magnetic Haemoflitration System.
MediSieve Receives Industry Recognition

MediSieve Receives Industry Recognition
April 02, 2022

MediSieve, a biotech company that has developed an innovative blood filtration device, receives recognition and approval from the industry.